CADAP Joint Regional Conference on new psychoactive substances (NPS)

Central Asia Drug Action Programme (CADAP Phase 6) represents continuity of the EU policy and long term engagement with Central Asian partners to help further strengthen their national policies in drug demand reduction. The beneficiaries of CADAP 6 include policy makers, drug experts, penitentiary and hospital staff, media professionals, teachers, drug users, prisoners, young people and the general public.